Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pafencil

Known as: 4-di(2-chloroethyl)aminophenacetyl-4-aminobenzoic acid, paphencil, paphencyl 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Clinical and laboratory indications of hemocoagulatory disorders (according to the data of electrocoagulograph H-334 and red… Expand
Is this relevant?
1991
1991
Three different programs of polychemotherapy (PCT) of multiple myeloma (MM) were compared. The programs included the use of… Expand
Is this relevant?
1989
1989
 
Is this relevant?
1985
1985
Pafencyl, a new antineoplastic drug, approved for use in the USSR, was administered orally to Wistar rats bearing subcutaneous… Expand
Is this relevant?
1985
1985
Pafencyl, a new antineoplastic drug, approved for use in the USSR, was administered orally to Wistar rats bearing subcutaneous… Expand
Is this relevant?
1982
1982
It has been found that paphencyl, preparations II-72 and II-119 decrease to an equal measure the leukocyte count in the… Expand
Is this relevant?
1981
1981
Experiments on CBA mice immunized with sheep red blood cells have shown that paphencyl, promycil, prospidin and imidazole-4… Expand
Is this relevant?
1981
1981
The paper deals with a comparison of the results of treatment of 19 patients with malignant lymphomas, mostly diffuse ones, stage… Expand
Is this relevant?